ZA9210079B - Alpha-substituted benzenemethanamine derivatives - Google Patents

Alpha-substituted benzenemethanamine derivatives

Info

Publication number
ZA9210079B
ZA9210079B ZA9210079A ZA9210079A ZA9210079B ZA 9210079 B ZA9210079 B ZA 9210079B ZA 9210079 A ZA9210079 A ZA 9210079A ZA 9210079 A ZA9210079 A ZA 9210079A ZA 9210079 B ZA9210079 B ZA 9210079B
Authority
ZA
South Africa
Prior art keywords
alpha
substituted
benzenemethanamine derivatives
benzenemethanamine
derivatives
Prior art date
Application number
ZA9210079A
Other languages
English (en)
Inventor
Marcel August Constant Janssen
Jean-Paul Rene Marie A Bosmans
Karin Josepha Malvina M Nuyens
George Henri Paul Van Daele
Frans Maria Alfons Van Keybus
Paul Adriaan Jan Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA9210079B publication Critical patent/ZA9210079B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9210079A 1991-12-30 1992-12-29 Alpha-substituted benzenemethanamine derivatives ZA9210079B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203430 1991-12-30

Publications (1)

Publication Number Publication Date
ZA9210079B true ZA9210079B (en) 1994-06-29

Family

ID=8208118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9210079A ZA9210079B (en) 1991-12-30 1992-12-29 Alpha-substituted benzenemethanamine derivatives

Country Status (17)

Country Link
US (2) US5407961A (xx)
EP (1) EP0620809B1 (xx)
JP (1) JPH07502524A (xx)
CN (1) CN1033451C (xx)
AP (1) AP406A (xx)
AT (1) ATE149484T1 (xx)
AU (1) AU664874B2 (xx)
CA (1) CA2125676A1 (xx)
DE (1) DE69217992T2 (xx)
FI (1) FI943120A0 (xx)
HU (1) HUT67030A (xx)
IL (1) IL104258A (xx)
MX (1) MX9207620A (xx)
NO (1) NO942481D0 (xx)
TW (1) TW249227B (xx)
WO (1) WO1993013052A1 (xx)
ZA (1) ZA9210079B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
PL183499B1 (pl) 1994-10-21 2002-06-28 Nps Pharma Inc Związki do modulowania receptorów wapniowych i kompozycje farmaceutyczne
US5981599A (en) 1996-05-01 1999-11-09 Nps Pharmaceuticals, Inc. Inorganic ion receptor active compounds
BR9911385A (pt) * 1998-06-19 2001-03-13 Us Health Composição, processos para dissociar um ìon de metal de uma proteìna contendo dedo de zinco, para inativar um vìrus e para selecionar um composto capaz de dissociar um ìon de metal quelado com um dedo de zinco de uma proteìna viral, vìrus isolado e inativado, kit para selecionar um composto capaz de dissociar um ìon de metal de um dedo de zinco de uma proteìna viral, composição viricida, e, formulação farmacêutica.
EP1104239B1 (de) 1998-08-13 2004-02-18 Bayer CropScience GmbH Herbizide mittel mit acylierten aminophenylsulfonylharnstoffen
CA2716347C (en) 2008-02-21 2017-06-20 Sequoia Pharmaceuticals, Inc. Amino acid inhibitors of cytochrome p450

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
IT1226300B (it) * 1988-07-26 1990-12-27 Zambon Spa Processo per la preparazione di intermedi per la sintesi del diltiazem.
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives

Also Published As

Publication number Publication date
IL104258A0 (en) 1993-05-13
JPH07502524A (ja) 1995-03-16
AU3258193A (en) 1993-07-28
AU664874B2 (en) 1995-12-07
DE69217992D1 (de) 1997-04-10
CA2125676A1 (en) 1993-07-08
CN1033451C (zh) 1996-12-04
FI943120A (fi) 1994-06-29
FI943120A0 (fi) 1994-06-29
US5480912A (en) 1996-01-02
ATE149484T1 (de) 1997-03-15
NO942481L (xx) 1994-06-30
HUT67030A (en) 1995-01-30
US5407961A (en) 1995-04-18
DE69217992T2 (de) 1997-06-12
IL104258A (en) 1997-04-15
EP0620809A1 (en) 1994-10-26
WO1993013052A1 (en) 1993-07-08
CN1073936A (zh) 1993-07-07
MX9207620A (es) 1993-06-01
HU9401381D0 (en) 1994-08-29
NO942481D0 (xx) 1994-06-30
TW249227B (xx) 1995-06-11
EP0620809B1 (en) 1997-03-05
AP406A (en) 1995-09-22
AP9200469A0 (en) 1993-01-31

Similar Documents

Publication Publication Date Title
GR3023621T3 (en) 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives
EP0520277A3 (en) 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives
HU9203994D0 (en) Imidazo-pyridine derivatives
PH30227A (en) 7-Isoindolinyl-quinolone-carboxylic acid derivatives
IL103538A0 (en) Quinoxaline-carboxylic and-phosphonic acid derivatives
KR960009119B1 (en) 16-dehydro vitamine d3 derivatives
HU9202768D0 (en) Cyano-phenyl-pyrrole derivatives
HU9203123D0 (en) Substituted imidazolyl-propenic acid derivatives
HU9401381D0 (en) Alpha-substituted benzenemethanamine derivatives
HU9202388D0 (en) Aryl-alkyl-amine derivatives
ZA92278B (en) 3-quinuclidine derivatives
HU9203124D0 (en) Imidazolyl-propenic acid derivatives
OA09716A (en) Benzoxaiole derivatives.
ZA922976B (en) 4-Aryl-3-heteroarylureidoquinoline derivatives
EP0520435A3 (en) Dc-89 derivatives
ZA9210078B (en) Heterocycle-substituted benzenemethanamine derivatives
HU9302728D0 (en) Pyridazinone-acetic acid derivatives
HU9200011D0 (en) Trifluoro-methyl-1-carba(1-dethia)-cepheme derivatives
GB2262739B (en) Benzofuranylimidazole derivatives
GB9102423D0 (en) Pryimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives
HU9200105D0 (en) Bipiridyl derivatives
GB9208156D0 (en) Dyes
HU9202296D0 (en) 3,4-dehydro-piperidine derivatives
ZA922831B (en) Novel thienyl-nonatetraenoic acid derivatives
GB9213972D0 (en) 3-cycloalkyl-prop-2-enamide derivatives